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Background: Mesenchymal stem cells (MSCs) can regenerate missing tissues and treat diseases. Hence, the current 
work aimed to compare the proliferation rate and the osteogenic differentiation potential of bone marrow MSCs 
(BMSCs), gingival MSCs (GMSCs) and submandibular MSCs (SMSCs). 
Material and Methods: MSCs derived from bone marrow, gingiva and submandibular salivary gland were isolated 
and cultured from rats. The proliferation capacity was judged by MTT proliferation Assay. Osteogenic differentia-
tion was assessed by Alzarin red stain and quantitative RT-PCR was performed for Runx-2 and MMP-13. 
Results: the highest significant proliferation was estimated in the BMSCs compared to GMSCs and SMSCs (p-
value was < 0.01). All studied cell types formed mineralized nodules as stained with Alizarin Red stain at the 3rd 
passage of differentiation. However, BMSCs seemed to generate the highest level of mineralization compared to 
GMSCs and SMSCs. RT-PCR revealed that the expression of Runx-2 and MMP-13 mRNAs was significantly in-
creased in the BMSCs compared to GMSCs and SMSCs (p-value was < 0.01). 
Conclusions: BMSCs displayed maximum osteogenesis results followed by the GMSCs and lastly by the SGSCs. 
Thus, it could be recommended that GMSCs can be used as a second choice after BMSCs when bone tissue recons-
truction is needed.




Mesenchymal stem cells (MSCs) are the most promising 
stem cells for clinical applications; they were originally 
found in the bone marrow, and have also been isolated 
from many other tissues as skin, adipose tissue and va-
rious dental tissues (1,2). Human bone marrow MSCs 
from the bone marrow (BMSCs) were  distinguished 
as multipotent stem cells by signifying their separation, 
growth in culture and directed differentiation to osteo-
genic, adipogenic and chondrogenic lineages (3). Stem 
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cell plasticity was clarified by the capability of MSCs to 
differentiate into lineages that are not typical mesenchy-
mal derivatives (4).
Regarding dental originated sources, gingival MSCs 
(GMSCs) comprise more interesting alternatives to the 
other dental MSCs as they are much easier to get from 
the clinically resected gingival tissues. Therefore, it is 
of great concern to prove the multiple differentiation 
potentials of GMSCs for possible tissue engineering 
applications (5). GMSCs have an obvious osteogenic 
potential. GMSCs from all biopsies were successfully 
isolated, characterized and expanded to clinically signi-
ficant numbers (>1 9 107 cells) in 3–5 passages. Multi-
lineage, including osteogenic, differentiation in standard 
culture was confirmed by staining assays and gene ex-
pression (6). The salivary glands derived from the en-
doderm and consist of acinar and ductal epithelial cells. 
Salivary gland stem/progenitor cells (SMSCs) were iso-
lated from the rat submandibular glands and investigated 
that the cells are rapidly proliferative and express aci-
nar, ductal and myoepithelial cell lineage markers (7). 
We investigated and compared the proliferation rate and 
the osteogenic differentiation potential of different adult 




All experiments will be conducted in the animal house of 
the Faculty of Medicine, Cairo University, Egypt accor-
ding to the recommendations and approval of the Ethics 
Committee on animal’s experimentation of the Faculty 
of Oral and Dental Medicine, Cairo University.
-Experimental procedures
A total of six rats were used in the current study in or-
der to obtain the bone marrow, gingival samples and the 
submandibular salivary gland samples. 
All animals will be euthanized by intracardiac overdose 
of sodium thiopental.
-Bone marrow mesenchymal stem cells
Bone marrow cells were flushed from tibia and fibula 
with phosphate-buffered saline (PBS) containing 2 mM 
EDTA. Over 15 ml Ficoll-Paque (Gibco-Invitrogen), 35 
ml of the diluted sample was carefully layered, centrifu-
ged for 35 minutes at 400xg rpm and the upper layer was 
aspirated leaving undisturbed mononuclear cell (MNC) 
layer at the interphase. This MNC layer was aspirated, 
washed twice in PBS containing 2 mM EDTA and cen-
trifuged for 10 minutes at 200xg rpm at 10 ºC. The cell 
pellet was re-suspended in a final volume of 300 μl of 
buffer. Isolated MSCs were cultured on 25 ml culture 
flasks in minimal essential medium (MEM) supplemen-
ted with 15% fetal bovine serum (FBS) and incubated at 
37°C and 5% CO2. Adherent MSCs were maintained in 
culture media MEM supplemented with 15% FBS, 0.5% 
penicillin, and streptomycin at 37°C in 5% CO2 incu-
bator for 10-14 days until reaching 70-80% confluence 
(8). Cultures confluence was monitored by inverted mi-
croscope software image analysis and a digital camera 
was used for capturing images.
-Gingival mesenchymal stem cells
Gingival tissues were dissected from. Gingival stem 
cells were isolated by enzymatic digestion with Colla-
genase II (Sigma-Aldrich) and incubated for 2 hours at 
37°C (9). Cells were plated in 25 ml culture flasks and 
proliferated in minimal essential medium (MEM) (Gib-
co-Life Technologies) supplemented with 15% fetal bo-
vine serum (FBS), 1× Pen/Strep antibiotics (Invitrogen) 
and incubated at 37°C and 5% CO2. Cell Culture media 
were changed twice a week; with supplementation of L-
Ascorbic Acid 2-Phosphate (50 μg/mL; Sigma-Aldrich) 
and they were monitored for 70 to 80% confluence by 
using inverted microscope software. 
-Salivary mesenchymal stem cells
Primary salispheres were cultured as published pre-
viously (10). In brief, cell suspensions were prepared 
first by mechanical disruption with sterile scissor fo-
llowed by enzymatic digestion with collagenase II (0.63 
mg/ml; Gibco). After washing thoroughly, cell suspen-
sions were resuspended in DMEM/F12 medium contai-
ning 1× Pen/Strep antibiotics (Invitrogen), EGF (20 ng/
ml; Sigma-Aldrich), FGF2 (20 ng/ml; Sigma-Aldrich), 
insulin (10 μg/ml; Sigma-Aldrich), and dexamethasone 
(1 μM; Sigma-Aldrich), at a density of 400,000 cells per 
well of a 12-well plate. Cell culture media was changed 
twice a week, until they reached 70 to 80% of confluen-
ce. Inverted microscope software image analysis was 
used to assess vitality and confluence of cultured cells.
-MTT proliferation Assay
The MTT Reagent and Detergent Solution were obtai-
ned from TACSTM TREVIGEN® supplied ready for 
use. Cells (103-105) were cultured in 100 µl of culture 
medium in a flat-bottomed 96 well plate (tissue cultu-
re grade). The MTT reagent and detergent reagent were 
added to each well. The absorbance in each well was 
measured at a range from 490 to 630 nm using an enzy-
me-linked immunosorbent assay plate reader (Dynatech 
MRX 5000; Dynex). 
-Osteogenic differentiation
At three passage of subcultures, 2×103 of BMSCs, 2×103 
GMSCs and 2×103 of SMSCs were plated in each well 
of a flat-bottom 24-well plate with 1 mL of culture me-
dium. Osteogenic differentiation and mineralization was 
initiated 24 h after plating by replacing culture medium 
with DMEM supplemented with 10% FBS, 100 nM 
dexamethasone, 50 μg/mL ascorbic acid-2-phosphate. 
For mineralization, 10 mM β-glycerophosphate was 
added to osteogenic medium. Staining with Alzarin red 
was applied to each culture to assess BMSCs, GMSCs 
and SMSCs differentiation into osteoblasts (11).
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-Quantitative real time PCR
All studied cells were collected and subjected to RNA 
extraction using Qiagene cells/tissue extraction kit (Qia-
gene) according to manufacture instructions. The mRNA 
expression level was quantified by qRT–PCR. 1000 ng 
of the total RNA from each sample were used for cDNA 
synthesis by reverse transcription using High capacity 
cDNA Reverse Transcriptase kit (Applied Biosystem). 
The cDNA was subsequently amplified with the Syber 
Green I PCR Master Kit (Fermentas) in a 48-well plate 
using the Step One instrument (Applied Biosystem) as 
follows: 10 minutes at 95 ºC for enzyme activation fo-
llowed by 40 cycles of 15 seconds at 95ºC, 20 seconds at 
55 ºC and 30 seconds at 72 ºC for the amplification step. 
We used 1 μM of both primers specific for each selec-
ted gene including Runt-related transcription factor-2, 
matrix metalloproteinase-13 (RUNX-2, MMP-13) and 
GAPDH.  Primers sequence specific for each gene was 
demonstrated in table 1. Changes in the expression of 
each target gene were normalized relative to the mean 
critical threshold (CT) values of GAPDH housekeeping 
gene by the ΔΔCt method. 
-Statistical analysis
Data were statistically described in terms of mean ± stan-
dard deviation (± SD), median and range, or frequencies 
(number of cases) and percentages when appropriate. 
Comparison of numerical variables between the study 
groups was done using Kruskal Wallis test with post hoc 
multiple 2-group comparisons. P values less than 0.05 
was considered statistically significant. All statistical 
calculations were done using computer program SPSS 
(Statistical Package for the Social Science; SPSS Inc., 
release 15 for Microsoft Windows 2006).
Results
-Isolation and Culture of BMSCs, GMSCs and SMSCs
No differences were observed in the morphological cha-
racteristics of BMSCs, GMSCs and SMSCs at one and 
two weeks of culture. All the three groups achieved the 
spindle fusiform shaped like cells in morphology.
-MTT proliferation Assay
Measuring the MTT color absorbance among the three 
studied groups revealed that the highest significant pro-
liferation was observed at two weeks culture in BMSCs 
(2.416±0.744), followed by GMSCs (1.281±0.577) and 
finally SMSCs (0.226±0.0225) (Table 2). At 7&14 days 
culture there was a statistically highly significant diffe-
rence between all the studied groups as the p-value was 
< 0.01.
-Osteogenic differentiation
Osteogenic differentiation and mineralization were evi-
denced by calcium deposits which formed orange red fa-













Table 1: Primers sequence specific for each studied gene.
Proliferation rate 
* p values
BM-MSCs GMSCs SMSCs 


















Table 2: Proliferation rate in the different studied groups (mean±SD).
P1: BM-MSCs Vs GMSCs, P2:    BM-MSCs Vs SMSCs and P3: GMSCs Vs SM-
SCs. * p values less than 0.05 was considered statistically significant.
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Fig. 3: SMSCs at 3rd passage differentiated into 
osteoblasts and stained with Alzarin red. (arrows 
indicating lower calcium mineralization depos-
its).
Fig. 1: BM-MSCs at 3rd passage differentiated 
into osteoblasts and stained with Alzarin red. 
(arrows showed higher calcium mineralization 
deposits compared to other groups).
Fig. 2: GMSCs at 3rd passage differentiated into 
osteoblasts and stained with Alzarin red. (arrows 
indicating moderate calcium mineralization de-
posits). 
cets around the differentiated cells. BM-MSCs, GMSCs 
and SMSCs formed mineralized nodules with Alizarin 
Red stain at the 3rd passage differentiation (Figs. 1-3 
respectively). The highest calcium deposits were obser-
ved in BM-MSCs compared to GMSCs and SMSCs. 
-Quantitative RT-PCR results
Quantitative RT-PCR revealed that the expression of 
Runx-2 and MMP-13 mRNAs was increased in the 
BM-MSCs followed by the GMSCs group and lastly the 
SMSCs (Tables 2,3).
Comparing the mean values ± SD for the three studied 
groups regarding the proliferation results at 7&14 days 
in culture and PCR results of Runx-2 showed that there 
was a statistically highly significant difference between 
the studied groups as the  p-value was < 0.01; while the 
PCR results of MMP-13 were statistically not significant 
as the p-value was > 0.05.
On the other hand, 2-groups comparison of the mean 
values ± SD as regard the proliferation results at 7&14 
days culture showed a statistically highly significant di-
fference between each pair of the studied groups as the 
p-value was < 0.01. 
Concerning the PCR results of Runx-2; a statistically 
highly significant difference occurred between the BM-
MSCs & GMSCs groups and BM-MSCs & SMSCs 
groups; while the difference between the GMSCs & 
SMSCs groups was statistically not significant as the p-
value was > 0.05. Besides, comparing the PCR results 
of MMP-13 between each pair of the studied groups 
revealed a statistically non-significant difference as the 
p-value was > 0.05 (Tables 2,3).
Discussion
Stem cells are expected to provide a novel alternative 
to regenerate large defects in periodontal tissues and 





















Table 3: Quantitative RT-PCR results of RUNX-2 and MMP-13 genes expression (mean±SD).
P1: BM-MSCs Vs GMSCs, P2:    BM-MSCs Vs SMSCs and P3: GMSCs Vs SMSCs. * p values less 
than 0.05 was considered statistically significant.
alveolar bone (12). In the maxillofacial region, adult 
mesenchymal stem cells (MSCs) have been characte-
rized in several oral and para-oral tissues, which sug-
gests that these tissues could represent rich sources of 
stem cells, and in turn, could be used as alternatives for 
other conventional stem cell sources like bone marrow 
for example. This, in turn, has motivated us to carry out 
an in vitro study comparing the proliferation rate and 
osteogenic potential of MSCs obtained from various 
sources: bone marrow, gingiva and submandibular sa-
livary glands. BMSCs can be easily isolated from the 
bone marrow of iliac crest by physicians, but the bone 
marrow aspiration procedure is invasive for the donors. 
However, the stem cells most commonly used to date 
for bone regeneration in dental patients are BMSCs ob-
tained from the iliac crest, owing to their great potential 
for bone regeneration (13). Other stem cells in the oral 
mucosa have been identified in the lamina propria of 
the gingiva, which attaches directly to the periosteum 
of the underlying bone with no intervening submucosa 
(14). The gingiva overlying the alveolar ridges and the 
retromolar region is frequently resected during ordinary 
dental treatments and thus, can often be obtained as a 
discarded biological sample. GMSCs exhibited clono-
genicity, self-renewal and a multipotent differentiation 
capacity similar to that of BMSCs. However, they proli-
ferate faster than BMSCs, display a stable morphology 
and don’t lose their MSC characteristics with extended 
passaging (15). The multipotency of GMSCs and their 
ease of isolation, clinical abundance and rapid in vitro 
expansion provide a great advantage for this source as a 
stem cell source for potential clinical applications. 
Concerning stem cells in adult salivary gland, they are 
expected to be useful for autologous transplantation the-
rapy in case of tissue engineered-salivary glands or di-
rect cell therapy. SMSC could be directed to differentiate 
into adipogenic, osteogenic and chondrogenic cells (16). 
Long-term intake of glucocorticoids would cause osteo-
porosis and decreased osteoblastic activity which ulti-
mately can result in Cushing’s syndrome (17). In addi-
tion, dexamethasone when used for a long time would 
be toxic to the differentiated osteoblasts, hence, the cells 
have to be soon harvested and used after full differen-
tiation (18). Osteogenic differentiation media contain 
dexamethasone, ascorbic acid and β- glycerophosphate 
(β-GP) was used to support the osteogenic differentiation 
of mesenchymal stem cells in vitro. However, the exact 
mechanism by which β-glycerophosphate can induce 
mineralization   remains unclear, but it is believed that 
alkaline phosphatase can hydrolyze organic   phosphate 
and release inorganic phosphate which in turn can pro-
mote mineral deposition on the surface of tissue culture 
plastic and other materials (19). Organic phosphates are 
known to aid osteogenesis by starting mineralization in 
cell cultures and they were suggested to modulate osteo-
blastic activities by promoting a bone-like mineral phase 
(20). Mesenchymal stem cells are shown to undergo os-
teogenic differentiation when they are grown on minera-
lized surfaces which might be owing to the presence of 
osteopontin which strongly adsorbs to the charged mi-
neral phases created by presence of β-glycerolphosphate 
and other organic phosphates (21). Mineralization is not 
solely affected by the exogenously-added free phospha-
te groups, but also cell density plays an important role 
in mineralization. Higher MSCs seeding densities would 
lead to significantly more mineralization, demonstrating 
that a certain threshold cell density should be reached 
before mineralization. Furthermore, cultures that were 
allowed to concentrate their soluble products in the me-
dia produce more mineralized matrix indicating an auto-
crine or paracrine role of factors synthesized by MSCs 
which are undergoing osteogenic differentiation (22). 
Consequently, these results could explain our findings, 
where the greatest amount of mineralization; as detected 
by the alizarin red stained nodules, was observed among 
the BMSCs group as compared to the other two groups, 
which could be owing to the higher cell density and thus 
higher mineralization.
Regarding the in vitro MTT proliferation results for the 
cultured cells; the significant proliferation was noticed 
among the BMSCs. Maximum proliferation was achie-
ved at 14 days for the three studied groups. A statistica-
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lly highly significant difference was noticed among the 
three studied groups as the p-value was < 0.01. 
The core binding factor (Cbfa1) gene, also referred to 
as runt-related transcription factor-2 (Runx-2), and acu-
te myelogenous leukemia factor (AML-3), encodes a 
transcription factor that shares homology with the Dro-
sophila segmentation gene product Runt (23,24) and 
plays a key role in osteoblastic differentiation (25). The 
role of Runx-2 protein  in bone formation has been de-
monstrated in Runx-2 deficient mice which manifest a 
total absence of osteogenesis (25). In addition, genetic 
mutations in Runx-2 gene have been associated with 
multiple skeletal abnormalities in patients with clei-
docranial dysplasia syndrome (26). Hence, in the pre-
sent investigation, the increased expression of Runx-2 
among the BMSCs group could suggest more enhanced 
osteoblastic differentiation in this group. A statistically 
highly significant difference in the expression of Runx-2 
occurred among the three studied groups as the p-value 
was < 0.01.
Matrix Metalloproteinase 13 (MMP13, also called co-
llagenase-3) is a member of the large family of matrix 
metalloproteinases. This is a family of extracellular ma-
trix-degrading enzymes having several common structu-
ral features. They are endopeptidases which regulate cell 
growth, migration, and extracellular matrix remodeling 
(27). 
MMP13 has been considered to have an essential role in 
bone biology owing to its exclusive presence in the ske-
leton during development. MMP13 plays an important 
role in the degradation of components of the extrace-
llular matrix, particularly collagens. It degrades mainly 
collagen type II, but also collagens type I, III, and X, 
which are the major components of cartilage and bone 
(28). MMP13 knockout mice fail to undergo normal 
ossification with a delay in ossification at the primary 
centers (29). Because of these findings, MMP13 is con-
sidered important in bone formation and remodeling and 
hence, it was selected in the present work to investigate 
the osteoblastic differentiation of the studied MSCs. The 
current PCR results of MMP-13 revealed that its ex-
pression was significantly increased among the BMSCs 
group compared to GMSCs and to SGSCs. However, the 
differences among the studied three groups were statisti-
cally not significant as the p-value was > 0.05.
According to the obtained results in the current investi-
gation, it could be concluded that MSCs from different 
sources possess an osteogenic potential as they could be 
differentiated into osteoblasts and could produce mine-
ralized nodules, when cultured in the proper osteogenic 
medium. This was supported by alizarin red staining re-
sults and by RT-PCR examination for the expression of 
Runx-2 and MMP-13 genes. 
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